ArticleCureus2026
Neutrophil CD64, CD66b, and Serum Thioredoxin as Early Biomarkers of Delayed Fracture-Related Infection After Internal Fixation: A Prospective Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDelayed fracture-related infection (FRI) remains a major complication after internal fixation, and conventional inflammatory markers have limited diagnostic accuracy. This study evaluated neutrophil CD64, CD66b, and serum thioredoxin as adjunctive biomarkers for delayed FRI.
methodsIn this prospective cohort study at a tertiary trauma center, 637 patients undergoing internal fixation for long-bone fractures were enrolled and followed until fracture union. Venous blood was collected pre-operatively and on postoperative days 3, 7, and 10. Total leucocyte count (TLC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), neutrophil CD64 and CD66b, and serum thioredoxin were measured. FRI was defined using contemporary clinicoradiological and microbiological consensus criteria. Diagnostic performance was assessed by receiver operating characteristic (ROC) analysis.
resultsDelayed FRI occurred in 56/637 patients (8.8%). FRI was associated with open fractures (30.4% vs 9.0%) and Tscherne grade ≥2 (78.6% vs 61.1%) and significantly prolonged time to union (21.84 ± 6.92 vs 16.26 ± 3.42 weeks; p < 0.0001). From day 3 onward, TLC, ESR, and CRP were significantly higher in the FRI group; CRP on day 7 showed the best conventional performance (cut-off >20 mg/L; sensitivity 83%, specificity 80%, AUC 0.85). CD64, CD66b, and thioredoxin diverged sharply between groups. CD64 on day 10 (cut-off >3800 median fluorescence intensity (MFI)) yielded a sensitivity of 91%, a specificity of 87%, NPV of 99% (AUC 0.93). CD66b on day 3 (>450 MFI) and thioredoxin on day 7 (>85 ng/mL) showed AUCs of 0.87 and 0.89 with NPVs of 98%.
conclusionNeutrophil CD64, CD66b, and serum thioredoxin outperform conventional markers for detecting delayed FRI and, in combination, provide a high-negative predictive value panel that may substantially improve early diagnosis and safe exclusion of infection after fracture fixation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.